877 related articles for article (PubMed ID: 29078029)
1. Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.
Pagano G; Yousaf T; Wilson H; Niccolini F; Polychronis S; Chaudhuri KR; Politis M
Eur J Neurol; 2018 Feb; 25(2):307-312. PubMed ID: 29078029
[TBL] [Abstract][Full Text] [Related]
2. Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease.
Liu R; Umbach DM; Tröster AI; Huang X; Chen H
Parkinsonism Relat Disord; 2020 Mar; 72():23-30. PubMed ID: 32092703
[TBL] [Abstract][Full Text] [Related]
3. Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.
Noyce AJ; Dickson J; Rees RN; Bestwick JP; Isaias IU; Politis M; Giovannoni G; Warner TT; Lees AJ; Schrag A
Mov Disord; 2018 Mar; 33(3):478-482. PubMed ID: 29380907
[TBL] [Abstract][Full Text] [Related]
4. Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's disease.
Sampedro F; Marín-Lahoz J; Martínez-Horta S; Camacho V; Lopez-Mora DA; Pagonabarraga J; Kulisevsky J
Neurobiol Aging; 2021 Jan; 97():120-128. PubMed ID: 33212336
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
[TBL] [Abstract][Full Text] [Related]
6. Associations of striatal dopamine transporter binding with motor and non-motor symptoms in early Parkinson's disease.
Yang Z; Xie Y; Dou K; Yang L; Xie A
Clin Transl Sci; 2023 Jun; 16(6):1021-1038. PubMed ID: 36915231
[TBL] [Abstract][Full Text] [Related]
7. Relation of overactive bladder with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
Mito Y; Yabe I; Yaguchi H; Takei T; Terae S; Tajima Y
Parkinsonism Relat Disord; 2018 May; 50():37-41. PubMed ID: 29449184
[TBL] [Abstract][Full Text] [Related]
8. Speech difficulties in early de novo patients with Parkinson's disease.
Polychronis S; Niccolini F; Pagano G; Yousaf T; Politis M
Parkinsonism Relat Disord; 2019 Jul; 64():256-261. PubMed ID: 31078401
[TBL] [Abstract][Full Text] [Related]
9. Relations of clinical symptoms with dopamine transporter imaging in drug-naïve Parkinson's disease.
Mito Y; Yabe I; Yaguchi H; Sato C; Takei T; Terae S; Tajima Y
Clin Neurol Neurosurg; 2020 Sep; 196():105960. PubMed ID: 32593043
[TBL] [Abstract][Full Text] [Related]
10. Frequency of REM sleep behavior disorders in patients with Parkinson's disease.
Janković M; Svetel M; Kostić V
Vojnosanit Pregl; 2015 May; 72(5):442-6. PubMed ID: 26165053
[TBL] [Abstract][Full Text] [Related]
11. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
[TBL] [Abstract][Full Text] [Related]
12. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
Arnaldi D; De Carli F; Picco A; Ferrara M; Accardo J; Bossert I; Famà F; Girtler N; Morbelli S; Sambuceti G; Nobili F
Neurobiol Aging; 2015 Dec; 36(12):3300-3305. PubMed ID: 26410306
[TBL] [Abstract][Full Text] [Related]
13. Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
Jenkins PO; Roussakis AA; De Simoni S; Bourke N; Fleminger J; Cole J; Piccini P; Sharp D
J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):631-637. PubMed ID: 32381639
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.
Simuni T; Siderowf A; Lasch S; Coffey CS; Caspell-Garcia C; Jennings D; Tanner CM; Trojanowski JQ; Shaw LM; Seibyl J; Schuff N; Singleton A; Kieburtz K; Toga AW; Mollenhauer B; Galasko D; Chahine LM; Weintraub D; Foroud T; Tosun D; Poston K; Arnedo V; Frasier M; Sherer T; Chowdhury S; Marek K;
Mov Disord; 2018 May; 33(5):771-782. PubMed ID: 29572948
[TBL] [Abstract][Full Text] [Related]
15. REM sleep behavior disorder in early Parkinson's disease predicts the rapid dopaminergic denervation.
Kim YE; Kim YJ; Hwang HS; Ma HI
Parkinsonism Relat Disord; 2020 Nov; 80():120-126. PubMed ID: 32987358
[TBL] [Abstract][Full Text] [Related]
16. The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.
Pont-Sunyer C; Tolosa E; Caspell-Garcia C; Coffey C; Alcalay RN; Chan P; Duda JE; Facheris M; Fernández-Santiago R; Marek K; Lomeña F; Marras C; Mondragon E; Saunders-Pullman R; Waro B;
Mov Disord; 2017 May; 32(5):726-738. PubMed ID: 28370517
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
Mollenhauer B; Caspell-Garcia CJ; Coffey CS; Taylor P; Singleton A; Shaw LM; Trojanowski JQ; Frasier M; Simuni T; Iranzo A; Oertel W; Siderowf A; Weintraub D; Seibyl J; Toga AW; Tanner CM; Kieburtz K; Chahine LM; Marek K; Galasko D;
Mov Disord; 2019 Sep; 34(9):1354-1364. PubMed ID: 31361367
[TBL] [Abstract][Full Text] [Related]
18. Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease.
Roos DS; Twisk JWR; Raijmakers PGHM; Doty RL; Berendse HW
J Neural Transm (Vienna); 2019 Nov; 126(11):1471-1478. PubMed ID: 31515655
[TBL] [Abstract][Full Text] [Related]
19. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Pirker W
Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
[TBL] [Abstract][Full Text] [Related]
20. Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease.
Yousaf T; Pagano G; Niccolini F; Politis M
J Neurol Sci; 2018 Apr; 387():220-227. PubMed ID: 29571867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
